Jiaji Yu

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy”.

Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy

Nature Communications(2021)10.1038/s41467-021-23164-2

N/A

0DataRank · unranked

157 citations

Xi Wang, Jiaji Yu, Feiyang Ma, Zhe Li, Yang Zhou +11 more

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100449

N/A

0DataRank · unranked

104 citations

Yang Zhou, Kwang Gi Kim, Yanni Zhu, Feiyang Ma, Jiaji Yu +24 more

Targeting monoamine oxidase A for T cell–based cancer immunotherapy

Science Immunology(2021)10.1126/sciimmunol.abh2383

N/A

0DataRank · unranked

76 citations

Bo Li, Kwang Gi Kim, Yu-Chen Wang, Zhe Li, Jiaji Yu +16 more

Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention

Stem Cell Research & Therapy(2022)10.1186/s13287-022-02787-2

N/A

0DataRank · unranked

36 citations

Zachary Spencer Dunn, Gustavo Garcia, Camille Carmona, Yang Zhou, Derek Lee +7 more

Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapies

Nature Nanotechnology(2024)10.1038/s41565-024-01781-4

N/A

0DataRank · unranked

30 citations

Jiaji Yu, Yan-Ruide Li, Feiyang Ma, Yuchen Wang, Yang Liu +12 more